Viewing Study NCT06744205

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2026-03-13 @ 2:40 AM
Study NCT ID: NCT06744205
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-30
First Post: 2024-12-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and Older
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Influenza View
None Healthy Volunteers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None influenza, flu, vaccine, hexavalent View